| Names | |
|---|---|
| Preferred IUPAC name | N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutanamide |
| Other names | CMA 4-Chloro-2,5-dimethoxyacetoacetanilide N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutanamide |
| Pronunciation | /ˈfɔːr-klɔːrəʊ-tuː-faɪv-daɪˈmɛθɒksi-əˌsiːtəʊˌæsiːtəˈnɪlaɪd/ |
| Identifiers | |
| CAS Number | 51838-35-4 |
| 3D model (JSmol) | `3DModel_jmol='data("mol 3D coordinates or other format string for 4-Chloro-2,5-dimethoxyacetoacetanilide")'` |
| Beilstein Reference | 1011582 |
| ChEBI | CHEBI:94443 |
| ChEMBL | CHEMBL2104746 |
| ChemSpider | 21742717 |
| DrugBank | DB08797 |
| ECHA InfoCard | ECHA InfoCard: 100.044.079 |
| Gmelin Reference | Gmelin Reference: 82544 |
| KEGG | C18604 |
| MeSH | Dichlormid |
| PubChem CID | 21633225 |
| RTECS number | CM4375000 |
| UNII | MFZOC9124G |
| UN number | UN3077 |
| Properties | |
| Chemical formula | C12H14ClNO4 |
| Molar mass | 343.78 g/mol |
| Appearance | Light yellow solid |
| Odor | Odorless |
| Density | 1.32 g/cm³ |
| Solubility in water | Slightly soluble in water |
| log P | 1.98 |
| Acidity (pKa) | pKa = 7.85 |
| Basicity (pKb) | 6.31 |
| Magnetic susceptibility (χ) | -63.6·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.613 |
| Dipole moment | 3.94 Debye |
| Thermochemistry | |
| Std enthalpy of formation (ΔfH⦵298) | -510.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1199.5 kJ/mol |
| Pharmacology | |
| ATC code | N02BE03 |
| Hazards | |
| Main hazards | Harmful if swallowed or inhaled. Causes skin and eye irritation. May cause respiratory tract irritation. |
| GHS labelling | GHS07, GHS09 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P261, P264, P271, P272, P273, P280, P302+P352, P305+P351+P338, P308+P313, P333+P313, P337+P313, P363, P501 |
| Flash point | 160.5 °C |
| Lethal dose or concentration | LD50 oral rat 640 mg/kg |
| LD50 (median dose) | LD50 (median dose): Rat oral 640 mg/kg |
| NIOSH | RN28748 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg/m3 |
| IDLH (Immediate danger) | Not established |
| Property | Detail | Industrial Commentary |
|---|---|---|
| Product Name & IUPAC Name | 4-Chloro-2,5-dimethoxyacetoacetanilide IUPAC: N-(4-chloro-2,5-dimethoxyphenyl)-3-oxobutanamide |
This designation reflects the substitution pattern on the aromatic core, essential for targeting selectivity during synthesis. Choice of aniline and acetoacetyl precursors directs isomer outcome, with positional purity determined by strict precursor identity and reaction control. |
| Chemical Formula | C12H14ClNO4 | Batch-level elemental composition control governs formula accuracy. By monitoring reagent charge and conversion, technicians validate target stoichiometry, especially to limit over-chlorination and ensure functional group fidelity. Downstream purity analytics confirm minimal deviation from declared formula. |
| Synonyms & Trade Names | 4-Chloro-2,5-dimethoxyacetoacetanilide CDMAPA 4-Chloro-2,5-dimethoxy-N-acetoacetanilide |
Process streams reference material by synthesis batch or application-relevant shorthand. Synonym usage aligns with analytical documentation and regulatory submissions. Legacy and functional names depend on regional nomenclature and customer communication norms. |
| HS Code & Customs Classification | 2924.29 (Aromatic amides, acyclic amides and their derivatives, other) | HS code assignment impacts import/export documentation, duty calculation, and compliance obligations. Officials verify structural class and application end-use to apply correct tariff line. Manufacturers track regulatory clarifications to prevent misclassification disruptions at border controls. Grade-specific declarations may be required depending on end-use and region. |
Industrial-scale production of 4-Chloro-2,5-dimethoxyacetoacetanilide regularly delivers a solid, fine to crystalline powder. Color may range from off-white to pale yellow, depending on upstream process cleanliness and the degree of residual impurities after crystallization. Odor is not typically pronounced in purified lots, though minor aromatic notes can surface if process volatiles are insufficiently stripped.
Melting point and density values show modest batch-to-batch variation, heavily influenced by purity grade and drying parameters at final step-off. Values cannot be universally quoted; analytical determination on a per-lot basis remains best practice. Boiling point assessment has less relevance since decomposition precedes boiling under atmospheric conditions, a common scenario for substituted acetanilides in this category.
We observe chemical stability aligns with the absence of strong acids, bases, and oxidants during transport and storage. Dissolution or reaction with reactive species in downstream applications depends on substitution pattern and residual moisture content. No exothermic cross-reaction or notable instability detected under routine manufacturing or handling conditions.
Solubility parameters differ across grades, especially for pharmaceutical precursors or electronic applications. Aqueous solubility is quite low, consistent with related substituted acetanilides, and process engineers rely on small-polarity organic solvents for solution preparations. Choice of solvent—ethanol, methanol, dimethylformamide, dichloromethane—hinges on required purity, need for downstream drying, and user facility handling requirements.
Grade specification is not universal and follows both internal process control and direct customer specification. Typical values—assay, moisture, single major impurity—are defined by lot, with reference to application context: e.g., pharma-intermediate, dye, or lab use. Final release standard is subject to internal quality control criteria and customer requirements.
Process route, raw material batch, and purification strategy drive impurity profiles. We closely monitor for halogenated by-products, incompletely dimethoxylated anilides, and residual starting phenols. Limits align with agreed specs; absence of any particular impurity is not assumed unless a certificate of analysis specifically confirms it.
Assay, residual solvents, and specific impurities are evaluated using validated methods—usually HPLC for assay, GC for volatile solvent residues, and titration or spectroscopic techniques to identify specific by-products. Reference standards, wherever possible, are cross-checked against certified material and customer-supplied benchmarks.
Many manufactories consider the availability and purity of the chloroaniline and dimethoxyphenol core intermediates as a gating factor. Supplier approval covers heavy metal content and absence of extraneous halides. Each campaign commences with a thorough vetting of raw material COA and at least one incoming lot analysis.
Most plants follow an acylation pathway—condensing 4-chloro-2,5-dimethoxyaniline with appropriate acetoacetylating agents. Reaction mechanism favors control of pH and stoichiometry, with aqueous or low-polarity organic phase management essential to avoid side reactions. Catalysts and temperatures are chosen for yield and impurity minimization, often dictated by past campaign learnings and pilot data.
The main control point resides in stepwise addition and temperature ramping, designed to lower dimer and oligomer formation. Purification builds on staged recrystallization and multisolvent washes, the profile of which is customer and grade specific. Final drying controls both moisture and trace solvent residue.
Batch release depends on conformance to internally established assay and impurity profiles, as well as outcome of physical property tests. In-process controls focus on endpoint determination—verified by real-time analytics where setups permit. No batch moves forward without signoff from both manufacturing and quality control signatories.
Derivative manufacturing commonly targets further substitution on the aromatic core or amidation of the acetoacetyl group. Most plant-scale reactions take place under either mild basic or neutral conditions. Solvents—toluene, acetonitrile, alcohols—are picked for reaction efficiency rather than generic applicability.
Reaction temperature, catalyst loadings, and residence times are process- and customer-specific and undergo optimization during process development, with particular attention to the risk of over-chlorination or demethoxylation. All downstream modifications demand secondary purification, the scope and scale of which are worked out in collaboration with downstream formulators.
This acetoacetanilide base serves as a precursor for specialty dyes, light stabilizers, and custom pharmaceuticals. Modification chemistry depends on application sector. Derivatization yields, impurity carryover and scalability are routine feedback points from customers; our technical staff continues to work with end users on process adaptations.
Material integrity depends on sealed storage and avoidance of humidity ingress. Product exposure to heat increases the probability of decomposition and off-odor generation; storage rooms use climate controls based on product stability data from continuous monitoring campaigns. Light avoidance becomes critical for grades specified for electronic or diagnostic sector use.
Steel drums with inert liners or HDPE containers represent the most accepted bulk storage forms. Lid integrity, absence of reactive gaskets, and regular drum inspection address both quality and safety. Fill line operators visually inspect containers for any sign of previous use or potential contaminant carryover.
Shelf life becomes a function of process cleanliness, purification thoroughness, and packaging integrity. Any shift in color, agglomerate formation, or presence of odor leads to off-spec disposition and additional analysis. Fade in primary appearance metrics or quantifiable loss in assay triggers a retest protocol before release.
Hazard classification aligns with established data for halogenated acetanilides with alkoxy substituents; operator training focuses on skin, eye, and respiratory system protection. GHS pictograms and statements follow regulatory updates, not a static standard.
Chemical handling SOPs mandate use of gloves, goggles, and splash protection during all material handling, transfer, or charging operations. Processing areas fitted with local exhaust and spill mitigation kits. Disposal guidance always defers to relevant regional or facility-based environmental regulations.
Available toxicity data points towards limited but significant acute exposure risk, especially by inhalation of dust or accidental contact with unprotected skin. Inhalation thresholds and chronic exposure effects are reviewed as new data emerges. Team members receive practical training in emergency response, including first-aid and containment. Work areas always display relevant hazard and first-aid signage.
As a direct manufacturer of 4-Chloro-2,5-dimethoxyacetoacetanilide, capacity planning starts with raw material allocation and forecast accuracy. Batch sizes are set according to downstream commitments and receive weekly review based on both plant schedule and committed customer volume. Actual supply hinges on uninterrupted access to qualified aniline derivatives and methoxy precursors; sourcing bottlenecks or unexpected quality deviations at this stage are the main reason for temporal shortages. The product’s throughput will always depend on plant maintenance cycles and purification yield, which varies in complex syntheses with multiple oxidative or reductive steps. Dedicated reactor lines, when committed, offer more predictable supply for strategic accounts, but spot markets can see sudden lead time changes.
Lead times track closely with both batch cycle (typically determined by route complexity and purification regime) and final QC turnaround. Products shipped from the standard line may range from two to four weeks; expedited dispatch is feasible if upstream stocks of compliant intermediates exist. Lower purity or research grades usually allow faster delivery, while high-purity or custom-certified batches depend on analytical confirmation, which may extend total lead time. MOQ for commercial-grade supply reflects both handling efficiency and process-economics, with higher-purity forms typically requiring larger purchase volumes to justify custom campaigns.
Packaging choice comes down to product sensitivity and downstream application. Industrial lots are typically supplied in steel drums or HDPE containers with full sealing, though pharma- or fine-chem grade may call for inert-gas flushed, double-liner systems and tamper-proof labeling as part of chain-of-custody documentation. Outer packaging must comply with destination transport regulations—especially if the product requires classification for international shipping under specific hazard codes.
Exports ship under Incoterms that reflect customer risk tolerance and consignee requirements, with EXW, FOB, and CIF available for main ports. Payment terms get negotiated around first-lot qualification and credit review, with most repeat customers opting for standard net period following confirmation of analytical release. Insurance and documentation for regulated markets require co-ordination with compliance teams, especially for emerging markets subject to dual-use export controls or regional notification.
Input pricing reflects global movement in aromatic derivatives and acetoacetanilide cores. Cost bases directly tie to crude oil and aromatic substitution cycle, as feedstock cost pass-through is common from base chemical producers when supply tightens or raw material prices surge. The main cost drivers remain the specialty intermediates required for ortho/para- substitution protection and the level of synthetic purification, particularly for high-purity requirements where impurity rejection leads to material loss and higher energy consumption.
Rapid price swings most often come from upstream disruptions—force majeure at key precursor plants or tightening environmental audits in major chemical zones (especially in East China). Regulatory actions running from production curtailments to hazardous waste mandates add cost volatility as purification and waste management overhead grows. Other factors include transport surcharges for hazardous classification, seasonal demand spikes from downstream pigment or pharmaceutical cycles, and exchange rate turbulence for raw material imports.
High-purity or analytic grades carry a premium, driven by both process complexity and QMS burden: every additional point of purity may require exponentially more effort in distillation, recrystallization, or chromatographic purification. Product price sharply differentiates by grade and certification—pharmacopeia or reagent-standard material undergoes additional identity and impurity-profile confirmation. Downstream sector demands may also dictate tailored packaging (e.g., GMP warehouse protocol, anti-static systems), further adding to delivered unit cost.
World demand for 4-Chloro-2,5-dimethoxyacetoacetanilide ties most directly to specialty pigment and pharmaceutical intermediate markets, fluctuating with customer pipeline launches and regulatory-driven reformulations. Supply centers around integrated producers with both precursor and end-product capability, most notably in East and South Asia, occasional US/European specialty lines, and niche Japanese advanced-materials firms. Capacity swings most widely during periods of environmental crackdown or export restriction in key producing regions.
The US and EU mainly rely on imports, with local production focused on higher-end or specialty-certified grades under strict regulatory control and detailed traceability regimes. Demand spikes tend to align with innovation cycles in pharma/agribusiness. Japan’s sector favors certified lots and prefers long-term supplier vetting for product consistency. India and China cluster most manufacturing capacity and, during local regulatory crackdowns or export policy shifts, can quickly impact global availability or drive regional price breaks. Indian producers tend to benefit from lower compliance costs but face periodic volatility due to environmental or energy-related shutdowns, while Chinese supply stability depends on regional permitting and energy cost controls.
Current data suggest that 4-Chloro-2,5-dimethoxyacetoacetanilide prices in 2026 will hinge on two primary factors: the ongoing implementation of stricter environmental policy in China and the evolving cost basis for core aromatic raw materials. If recent cycles of supply-side reform persist, price floors could stay firm, with periodic spikes triggered by upstream plant outages or feedstock scarcity. The likelihood of rapid price declines appears low unless crude-derived intermediates experience sustained drop or new capacity is developed outside current main regions. Branded and certified product lines will maintain persistent price premiums due to higher compliance and quality control cost.
Price trend estimates draw on actual international trade data, in-house production forecasts, and regional compliance cost modeling. Market intelligence integrates feedback from industry roundtables and direct negotiation history with large buyers, cross-checked against published customs figures and independent chemical indices.
Raw material volatility increased across 2023–2024 due to upstream shutdowns and sharper import regulation in both China and India. Several producers experienced wave shutdowns in response to tightened air emission standards, impacting regional supply chains and causing fulfillment delays globally. Strategic end-users started to secure multi-year contracts to avoid spot market exposure, especially for pharmaceutical and pigment applications.
Tighter control on discharge and emissions across Asia’s chemical clusters continued to drive compliance-related process upgrades. Manufacturers responded by investing in pre-treatment and energy recovery infrastructure; these costs now factor heavily into quoted prices and long-term strategic planning. Markets with updated chemical registration expect formal data submission on impurity profiles and traceability, requiring robust change control and extended documentation packages.
Active mitigation measures include increasing inventory buffers of upstream intermediates, synchronizing batch schedules with environmental permit windows, and diversifying critical raw material sources to hedge against regional instability. Customer communication around lead time exposures and proactive allocation planning now forms a routine part of sales cycles, particularly for higher-grade or regulatory-sensitive grades.
4-Chloro-2,5-dimethoxyacetoacetanilide serves as an intermediate across several chemical manufacturing segments. Production experience places its main uses in pigment synthesis—particularly for arylide yellow pigments—where performance in shade, dispersibility, and thermal stability shapes downstream market acceptance. Beyond pigmentation, certain pharmaceutical intermediates draw from its core structure, with impurity thresholds and trace solvent residues playing a critical part in subsequent product registration dossiers. Specialty coatings and select agricultural research also incorporate this material; each sector imposes distinct requirements on trace metals, residual organics, and lot-to-lot reactivity.
| Application Field | Recommended Grade Profile | Critical Quality Attributes |
|---|---|---|
| Pigment Manufacturing | Technical Grade | Color strength, particle distribution, trace organic by-products |
| Pharmaceutical Intermediate Synthesis | High Purity Grade | Residual solvents, low heavy metal content, minimized related substances |
| Specialty Coatings | Controlled Purity Grade | UV stability, compatibility, batch uniformity |
| Agrochemical Research | Research Grade | Defined impurity profiles, detailed analytical support |
Technical grade batches target pigment lines and typically emphasize color intensity and ease of dispersion. Distributors consistently request batch reports detailing insoluble residue and by-product fingerprinting, as even minor batch shifts can trigger compatibility failures in end-process milling or extrusion. High purity grade production for pharma sectors requires extensive in-process controls to limit organochlorine by-products and residual acetic solvents. These grades differ in raw material pre-treatment steps and purification cycles—which increases production complexity and cost. For coatings, formulating chemists often supply their own custom cut-off values for UV absorbance and viscosity parameters; industrial release hinges on validating these against in-house reference standards.
Starting with a clear application description avoids costly misalignment across specification, supply chain, and regulatory demands. Formulators in pigment manufacturing may prize color consistency, whereas pharmaceutical teams require certificates tracing back to validated starting materials and continuous impurity tracking.
Each market and downstream application may trigger different documentation needs. Pharmaceutical supply, even as an intermediate, commonly triggers statements regarding residual solvents, compliance with relevant compendia, and detailed impurity tables. Pigment and coatings buyers may set limits based on national ecolabels or end-user tox-screening results. Grade differences often arise from which regulatory regime is in play and the scrutiny given to batch analytics.
Raw material selection forms the primary axis for purity outcomes. In pigment applications, a risk-based approach leads to using technical grade input with targeted controls on iron, copper, or lead. High purity production for pharmaceuticals requires additional pre-treatment steps, closed transfer, and multi-step chromatography or crystallization. The target impurity panel should be confirmed through customer analytics, as expectations vary sharply by region, customer history, and final product use.
Technical-grade production lines offer competitive pricing at bulk volumes, leveraging process scale. High purity lines require lower throughputs and incur higher analytical and purification overhead. This shifts cost curves—a key consideration for R&D projects compared to full-scale manufacturing. Experience shows that custom-grade requests, especially those involving extra cleaning validation or multiple analytical certificates, increase both per-kg cost and lead times.
Plant trials and pilot runs frequently demonstrate mismatches between internal test data and a customer’s in-process demands. Providing a batch sample for validation allows both sides to benchmark against application-relevant parameters—particle size, residual organics, filterability, and stability. Feedback from these trials informs final release specifications and ongoing production adjustments, ensuring actual field conditions drive grade criteria.
Each production batch of 4-Chloro-2,5-dimethoxyacetoacetanilide adheres to the company’s certified quality management system, subject to routine external audits. Certification scope covers not only product documentation, but also includes full traceability from raw material intake to finished product release. Audit trails extend through bulk, intermediates, technical controls, and packaging logistics. On the production floor, digital batch records link operator entries, materials tracking, and in-process analytics to support full compliance verification. Auditable data points include real-time process deviations, raw material source approval, and critical test values at stage gates. All certificates and quality declarations originate from the manufacturer’s internal QA and not from third-party intermediaries.
Certification packages can differ based on customer industry, locale, and grade. For some end-uses, additional analytical validations or regional compliance (such as country-specific chemical registrations or import pre-approval) may apply. Product-specific documentation can cover elemental impurities, organic contaminants, and physical properties, depending on use scenario. In regions that require independent third-party verification—for instance, REACH registration or food contact compliance—supporting documents issued directly from regulatory inspection or accredited laboratories accompany the standard material release file.
Manufacturing documentation includes batch-by-batch certificates of analysis, origin statements, and where required, GMP or ISO alignment evidence. Internal quality records define all measured analytical parameters based on release specification, with special emphasis on impurity profiles and residual solvents. Reports draw from line instrumentation and QA/QC labs with full sample retention protocol. Supplementary reports, such as stability trends or deviation reports, are available on request. These documents always correspond to the actual production route and batch, not third-party repack or trading stock.
Core production scheduling rests on consistent supply agreements with strategic sourcing of key raw materials. Long-term capacity planning reflects secure feedstock contracts and monitored production throughput. The plant maintains risk-mitigation protocols for single-point-sourcing by qualifying secondary suppliers for critical intermediates, supporting uninterrupted downstream supply. Scheduled plant maintenance and buffer inventory allocation serve as a hedge against supply interruptions for priority buyers.
Production capacity aligns with baseline contracted volumes. Flexibility comes from modular scheduling, allowing short campaign runs for specialty grades without impacting baseline product availability. Performance reviews of plant OEE (Overall Equipment Effectiveness) inform short-term adjustment in allocation during exceptional demand swings. For grade-switching, strict line clearance and validation cycles prevent cross-contamination between production runs. Customers with demand fluctuation can negotiate periodic volume reallocation within the contractual framework.
Sample provision involves direct coordination between technical support and customer QC, ensuring agreed targets for impurity profile, batch scale, and associated documentation are met prior to shipment. Requests for sample scale-up align with internal feasibility checks covering process stability at the desired scale. Shipping control tracks chain-of-custody documentation and temperature/exposure logs where required for product integrity. Feedback from sample evaluations feeds back into process adaptability reviews and, where justified, prompts finetuning for large-scale supply.
Business cooperation plans are structured around a tiered framework: fixed annual contracts with price locks, periodic spot purchasing, and volume-based rebates. Customers can alternate between standard-order lead times and short-notice pull orders within the scope of established supply calendars. Early-phase projects may commence supply through ‘tolling’ or ‘exclusive campaign’ models to control intellectual property exposure or for niche impurity control. For industries prone to rapid regulation change, supply terms include agile documentation updates and expedited regulatory support. All modes are subject to rolling review in formal supplier qualification audits to ensure up-to-date compliance and performance benchmarking.
In the technical departments, the most active research around 4-Chloro-2,5-dimethoxyacetoacetanilide focuses on purity improvement for high-value applications and process stabilization at production scale. Pharmaceutical intermediates often require impurity profiles tailored to end-use compliance. The quality control team pays particular attention to minimizing halogenated byproducts and reducing colored impurities that may form based on specific acetoacetanilide precursor selections or solvent effects during synthesis.
Raw material sourcing determines batch color stability and influences downstream filtration. Adaptive solvent strategies are being explored to optimize both yield and downstream waste management. Research teams are integrating latest advances in catalyst selection and solvent recycling to increase throughput with tighter control on environmental discharge.
Recent customer specifications suggest a shift toward applications demanding higher thermal stability and chemical compatibility. Colorant and pigment intermediates target lightfastness and application stability, prompting ongoing collaboration with formulators in both coatings and plastics sectors. These markets often request customized grades where specific spectral absorption or solubility profiles require process adjustments.
A recurring technical challenge involves the control of trace-metal contaminants, which directly arise from catalyst remnants or handling equipment. Several process iterations have yielded breakthroughs in refining crystallization and filtration conditions, targeting batch-to-batch reproducibility. Batch homogeneity is managed via in-process monitoring of both the main compound and minor side components, relying on real-time analytical feedback. Ongoing efforts aim to eliminate batch carryover via closed-system transfers and automation.
Industry partners forecast incremental demand growth from downstream users requiring tailored purity and performance consistency. Requests for application-specific grades are increasing, especially as end users in specialty chemicals and regulated sectors tighten specification controls. Regional variation in regulations may prompt diversification of release specifications and quality documentation. Technical teams expect more detailed documentation requests, especially for export-oriented customers.
Process evolution is expected to include greener solvent systems and increased automation to cut manual handling and minimize exposure incidents. Future reactor systems may integrate inline sensors for impurity markers unique to this intermediate. Emphasis is on real-time corrective actions during synthesis rather than end-point batch rejection. This allows for faster root-cause tracing and targeted improvements in process stages with the highest deviation risk.
In response to green chemistry initiatives, sustainability drives decisions on raw material origin, energy use, and solvent recovery. Recyclable solvent loops have reduced both cost and emissions, though integration varies depending on grade requirements. Purification strategies that minimize secondary waste streams receive preference in grade development meetings. There is active participation in consortiums benchmarking lifecycle impacts for fine organic intermediates. Waste minimization targets are now tied directly to internal key performance indicators within the production departments.
Engineers and technical specialists provide routine consultation on grade selection, application integration, and compliance alignment. Frequent queries involve optimizing storage and handling to prevent batch degradation, which can stem from temperature fluctuations or exposure to trace moisture. Consultation extends to customer pilot trials where unique process conditions prompt changes in delivery format or packaging.
Application performance depends on matching intermediate purity to downstream compatibility. Technical support engages directly with formulators to determine compatibility with customer-specific solvents or reactant systems. Support extends to analytical troubleshooting, such as identifying the sources of performance drift or incompatibility in finished formulations. Tailored recommendations for filtration and transfer processes sometimes address unique needs in pigment or pharmaceutical production environments.
After-sales follow-up is a structured process involving both quality and production staff. Feedback on off-spec events triggers an internal investigation that reviews batch history, release analytics, and supply chain handling. Commitment includes rapid response to technical complaints and joint development of corrective measures when deviations are traced to process variables. Repeat customers often require periodic review meetings where historical performance maps to targeted product improvement or documentation upgrades.
Decades of chemical production experience form the foundation of our work with 4-Chloro-2,5-dimethoxyacetoacetanilide. Control over each stage of synthesis—from raw material verification through final crystallization—remains a core strength. Optimizing reaction parameters and purification ensures consistency from lot to lot, meeting the demands of industrial processors who require reproducible product characteristics.
This compound finds primary use as an intermediate in dye and pigment manufacture. Producers in coatings, plastics, inks, and specialty chemical industries rely on its chemical profile for downstream synthesis. Applications in organic synthesis and advanced material compounds have increased as technical requirements become more exacting. Process engineers specify this chemical when batch-to-batch consistency and predictable reactivity are non-negotiable.
Every step — from in-house reaction control to particle sizing and drying — takes place in our facilities under a carefully designed quality management system. We run gravimetric and spectroscopic assays on both in-process and finished goods. This discipline permits uninterrupted operations in customer plants, as process chemists and formulators can plan production schedules with confidence in delivered chemical specifications.
Understanding logistics and on-site handling, we maintain a range of safe packaging solutions to serve bulk and batch users. Customized drum liners, sealed composite bags, and, for automated lines, FIBC options help large-volume clients minimize risk and waste. Our on-site storage and JIT supply programs address high-throughput manufacturing and seasonal ramp-ups, giving procurement managers reliable delivery options with long shelf stability.
Collaboration with client technical teams often starts before the first shipment. Our chemists stay available to address compatibility with existing equipment, process integration challenges, or transition trials. For clients scaling up or reformulating, on-site or remote troubleshooting speeds up implementation and reduces operational downtime. Data sheets come with real-world interpretation from our own engineers, not just regulatory text.
Direct control over specification, lead time, and documentation streamlines customer procurement. Long-term framework agreements shield supply chains from volatility, as our production scheduling accommodates blanket orders and forecast-based delivery adjustments. This capability supports distributors serving regional manufacturers and central buyers at multinational firms alike. Integration of advanced manufacturing and compliance standards further supports audit requirements, making business continuity a shared objective.
Producing 4-Chloro-2,5-dimethoxyacetoacetanilide to a consistent, verifiable standard requires stringent purity controls and robust analytical methods. From decades in chemical manufacturing, we know that both process reliability and downstream application performance depend on purity at every stage. From the starting raw material specification through to finished batch release, our quality assurance teams execute targeted checks that align with the best industry practice and evolving regulatory landscapes.
For 4-Chloro-2,5-dimethoxyacetoacetanilide, purity often exceeds 98% as determined by high-performance liquid chromatography (HPLC). Routine production batches undergo this quantitation as a release criterion. Impurity profiling remains equally critical: each shipment carries a detailed impurity fingerprint, and we provide chromatograms on request. We track residual solvents using validated gas chromatography (GC) protocols, with upper limits outlined for commonly encountered solvents in synthesis. Loss on drying is controlled by gravimetric analysis, ensuring limits are tightly controlled—moisture not only affects shelf stability but can impact downstream processing, so our QC technicians test every lot as a matter of routine.
We employ several orthogonal analytical techniques to confirm both identity and purity. HPLC with diode-array detection forms the backbone of our purity testing, with method parameters developed and refined by our in-house analytical chemists. GC provides a sensitive readout for volatile impurities and solvents, while infrared (IR) spectroscopy delivers clear qualitative identity checks based on the structure’s functional groups.
NMR spectroscopy enhances confirmation of molecular identity. For each campaign, our chemists record both 1H and 13C spectra, matching distinctive proton and carbon environments unique to the molecule. This approach uncovers even subtle batch-to-batch variation. Melting point analysis serves as a rapid screening tool for gross contamination or incorrect phase—critical when scale-up can sometimes introduce unexpected polymorphs or side products.
We regularly update and calibrate our reference standards against publicly available certified reference materials when accessible. Each certificate of analysis covers assay (by HPLC), impurity profile, moisture content, melting point, and residual solvent levels. Batch documentation includes chromatograms, spectra, and full method descriptions for traceability.
Our technical team develops new methodologies when customer requirements demand even tighter impurity limits or more sensitive detection of specific byproducts. We stay ahead by investing in the latest analytical technology—routine validations ensure accuracy and reliability across instruments and personnel. We invite audits, as independent validation only strengthens the confidence customers have in our products.
Consistent analytical rigor protects customers from surprises in formulation or research scale-up. As the direct manufacturer, we invite technical discussions to address unique project requirements, support regulatory filings, or design tailored specifications. By controlling each step from synthesis to final QC, we ensure that every batch backed by our label meets published standards not just on paper, but in practice, confirmed by reliable, transparent results.
From our position as an original manufacturer, questions about direct access to 4-chloro-2,5-dimethoxyacetoacetanilide often focus on production capacity, batch consistency, and ordering logistics far more than simple price lists. Customers who purchase from us expect factory-scale solutions and a direct technical back-and-forth, not third-hand delays. Our focus remains firmly on manufacturing integrity, which means the information here comes straight from practical chemical plant experience.
Our production facility maintains scheduled runs of 4-chloro-2,5-dimethoxyacetoacetanilide to ensure a steady supply chain for industrial users. With reaction setups tailored for syntheses requiring this compound as an intermediate, we support frequent requests from the pharmaceutical, dye, and specialty chemical sectors. Whenever production windows open, we coordinate to balance existing commitments with new bulk requests, which means availability correlates directly with ongoing batch schedules and pre-existing contracts.
We take inventory planning seriously because interruptions at the raw material or energy supply level affect lead times downstream. Bulk is not a vague promise here; it means packed drums or intermediate bulk containers directly at scales up to several metric tons in a typical campaign. By managing material flow, quality control, and reactor time internally, lead times and batch splits are facts we control, not variables introduced by outside handlers.
Minimum order quantity matters as much to us as it does to our clients. We guarantee consistency by setting MOQ at a level that reflects both sensible plant operation and optimized logistics. For this product, our MOQ sits at the level of a full production batch, which typically means at least one drum of finished product. Larger or repeat campaigns are handled with standing agreements, and for ongoing supply, we schedule recurring production.
Direct manufacturing involves more transparency on what it takes to fill an order. Our usual lead times run two to four weeks on standard MOQ, assuming unbroken supply lines and no dramatic volatility in upstream raw material markets. For urgent projects or ongoing supply contracts, we can reserve vessel time and arrange parallel synthesis to shrink lead times as much as possible. We use our own QC, our own operators, and our own packaging lines, so every step sits in our hands until final shipping.
For specialized applications, chemists expect proof of analysis and conformance. We supply batch analytical reports and can provide samples from pilot or commercial batches if needed for customer validation. Documentation covers both origin and traceability—every lot we ship includes manufacturing records and agreed-upon test reports. We encourage plant audit requests and technical dialogue for customers with proprietary process needs because problems tend to disappear with a transparent supply chain.
Reliable availability always comes down to strong planning and direct communication. Our technical managers keep an eye on both process optimization and long-range demand forecasts. We invest continuously in upstream sourcing, process safety, and production scheduling technology, knowing any bottleneck adds risk to both parties. Certain regulatory factors can impact global shipping; we handle export paperwork in-house, drawing on hands-on compliance training to move orders across borders without added bureaucracy.
As a pure manufacturer, our commitment to consistent bulk supply, clear minimum orders, and realistic lead times reflects both the realities and advantages of factory-direct sourcing—full control, flexibility, and technical capability without middleman uncertainty.
As the direct producer of 4-Chloro-2,5-dimethoxyacetoacetanilide, we have always paid attention to the physical behavior of this compound during packing, transit, and subsequent storage at destination facilities. Even though this substance does not rank among the most hazardous chemicals, it carries notable requirements that stem from both its molecular properties and applicable legislation.
4-Chloro-2,5-dimethoxyacetoacetanilide crystallizes as a solid with a moderate melting point. Our technical team has observed that the compound remains stable under ambient conditions. Flammability does not pose a concern for this material under normal storage temperatures. Sensitization and acute toxicity have not been flagged as prominent risks during our routine QC and bulk handling processes, but good practice dictates that accidental skin or eye contact is prevented. Our standard packaging—generally fiber drums with integrated liners or high-density polyethylene containers—guards against humidity contamination and incidental exposure.
Handling starts with trained staff at our facility, trained in best practices for solid chemical management. Operations rely on dust extraction points and enclosed transfer to keep airborne particulates low. Gloves and splash goggles serve as front-line protection; we do not permit open transfer in plant areas where ventilation is weak. Bulk shipments benefit from shrink-wrapping and moisture-barrier liners. At the receiving site, storage in a dry, cool, and ventilated warehouse away from acids, oxidizers, and strong bases aligns with protocols that have reduced cross-contamination risks over many years of shipping and warehousing experience.
Each export consignment leaves our factory accompanied by a Safety Data Sheet conforming to GHS requirements. Shipments follow national and international guidelines—including ADR, IMDG, or IATA where relevant. Our logistics documentation specifies the UN number or hazard class if regulated; at present, this compound has not triggered broad inclusion under the most stringent hazardous goods codes. Nonetheless, the regulatory landscape shifts, so our compliance teams monitor updates that influence labeling, secondary packaging, and handling stipulations. If regulations in your country require unique labeling or documentation, we can integrate these upon request, reflecting our commitment to seamless customs clearance and site acceptance.
We have extensive experience navigating regulatory hurdles across various jurisdictions. Some customers face local or sectoral rules for precursor chemicals, particularly those with aromatic substitution patterns. Our compliance staff can review intended applications to identify potential reporting or pre-approval needs. Waste streams should not enter public water or soil. End-users should collect and arrange for disposal in accordance with established chemical waste practices. These principles serve both compliance and environmental stewardship.
Direct oversight of each manufacturing, packaging, and shipping stage gives us practical knowledge that supports end-user safety, regulatory transparency, and uninterrupted supply. Our technical and compliance teams remain available to address technical questions or adapt documentation to fit changing regulatory scenarios—a responsibility we carry as the factory responsible for every gram shipped from our lines.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
